Company Overview of Pasteur Institute
25-28 Rue Doctor Droux
Key Executives for Pasteur Institute
Vice President and Head of Applications
Compensation as of Fiscal Year 2015.
Pasteur Institute Key Developments
Qatar's Supreme Council of Health Signs Five-Year Memorandum of Understanding with Institut Pasteur on R&D into Infectious Diseases and Immunology
Jan 8 16
Qatar's Supreme Council of Health (SCH) has signed a five-year memorandum of understanding with Institut Pasteur on R&D into infectious diseases and immunology. The partnership aims to increase collaboration in healthcare-related education, physician training, and research.
The Institut Carnot Curie Cancer Presents at BIO-Europe Spring 2015, Mar-10-2015 10:00 AM
Mar 6 15
The Institut Carnot Curie Cancer Presents at BIO-Europe Spring 2015, Mar-10-2015 10:00 AM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
Moderna Therapeutics Enters into Research Collaboration with Institut Pasteur
Feb 5 15
Moderna Therapeutics has entered into a long-term strategic research collaboration with Institut Pasteur. The contract has been signed to discover and develop drugs and vaccines using its mRNA Therapeutics platform. It will be managed by its venture company, Valera, which is focused on the advancement of vaccines and therapeutics for the prevention and treatment of viral, bacterial and parasitic infectious diseases. Under the deal, Valera will sponsor programmes of preclinical and clinical research at the Institut Pasteur, aimed at discovering and developing new approaches to combat known and emerging viral and bacterial diseases.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries